Cargando…
A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial
BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Prog...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369288/ https://www.ncbi.nlm.nih.gov/pubmed/34430937 http://dx.doi.org/10.1016/j.hroo.2021.06.003 |
_version_ | 1783739261484269568 |
---|---|
author | Dossett, Michelle L. Needles, Emma W. Donahue, Zachary Gadenne, Gillian Macklin, Eric A. Ruskin, Jeremy N. Denninger, John W. |
author_facet | Dossett, Michelle L. Needles, Emma W. Donahue, Zachary Gadenne, Gillian Macklin, Eric A. Ruskin, Jeremy N. Denninger, John W. |
author_sort | Dossett, Michelle L. |
collection | PubMed |
description | BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Program, on AF-related quality of life in patients with paroxysmal AF (PAF). METHODS: In this randomized, waitlist-controlled pilot trial, 18 subjects with PAF participated in an 8-week SMART Program delivered online immediately or 3 months later. Validated measures were completed at baseline and at 3 and 6 months (waitlist group only). RESULTS: Comparing pre- vs post-program scores among all 18 participants, subjects reported improvement in AF-related quality of life (Cohen’s d = 0.75, P = .005) and depression (d = 0.50, P = .05) but not anxiety (d = 0.35, P = .16). Subjects also reported improvements in AF symptom severity (P = .026), distress (P = .014), positive affect (P = .003), and ability to cope with stress (P = .001). Compared to waitlist control subjects, those in the immediate group reported improvement in positive affect (d = 1.20, P = .021) and coping with stress (d = 1.36, P = .011) after participating in the program. CONCLUSION: The SMART Program, delivered virtually, may enhance positive emotions and coping with stress as well as decrease negative emotions and AF symptoms. These results warrant a larger trial to better understand the potential benefits of such programs for patients with PAF. |
format | Online Article Text |
id | pubmed-8369288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83692882021-08-23 A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial Dossett, Michelle L. Needles, Emma W. Donahue, Zachary Gadenne, Gillian Macklin, Eric A. Ruskin, Jeremy N. Denninger, John W. Heart Rhythm O2 Clinical BACKGROUND: Stress and negative emotions contribute to atrial fibrillation (AF). Mind-body practices decrease stress and negative emotions and may reduce AF episodes and improve quality of life for patients with AF. OBJECTIVE: We examined the effects of a multimodal mind-body program, the SMART Program, on AF-related quality of life in patients with paroxysmal AF (PAF). METHODS: In this randomized, waitlist-controlled pilot trial, 18 subjects with PAF participated in an 8-week SMART Program delivered online immediately or 3 months later. Validated measures were completed at baseline and at 3 and 6 months (waitlist group only). RESULTS: Comparing pre- vs post-program scores among all 18 participants, subjects reported improvement in AF-related quality of life (Cohen’s d = 0.75, P = .005) and depression (d = 0.50, P = .05) but not anxiety (d = 0.35, P = .16). Subjects also reported improvements in AF symptom severity (P = .026), distress (P = .014), positive affect (P = .003), and ability to cope with stress (P = .001). Compared to waitlist control subjects, those in the immediate group reported improvement in positive affect (d = 1.20, P = .021) and coping with stress (d = 1.36, P = .011) after participating in the program. CONCLUSION: The SMART Program, delivered virtually, may enhance positive emotions and coping with stress as well as decrease negative emotions and AF symptoms. These results warrant a larger trial to better understand the potential benefits of such programs for patients with PAF. Elsevier 2021-06-22 /pmc/articles/PMC8369288/ /pubmed/34430937 http://dx.doi.org/10.1016/j.hroo.2021.06.003 Text en © 2021 Heart Rhythm Society. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Clinical Dossett, Michelle L. Needles, Emma W. Donahue, Zachary Gadenne, Gillian Macklin, Eric A. Ruskin, Jeremy N. Denninger, John W. A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title | A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title_full | A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title_fullStr | A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title_full_unstemmed | A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title_short | A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial |
title_sort | smart approach to reducing paroxysmal atrial fibrillation symptoms: results from a pilot randomized controlled trial |
topic | Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369288/ https://www.ncbi.nlm.nih.gov/pubmed/34430937 http://dx.doi.org/10.1016/j.hroo.2021.06.003 |
work_keys_str_mv | AT dossettmichellel asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT needlesemmaw asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT donahuezachary asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT gadennegillian asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT macklinerica asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT ruskinjeremyn asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT denningerjohnw asmartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT dossettmichellel smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT needlesemmaw smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT donahuezachary smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT gadennegillian smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT macklinerica smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT ruskinjeremyn smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial AT denningerjohnw smartapproachtoreducingparoxysmalatrialfibrillationsymptomsresultsfromapilotrandomizedcontrolledtrial |